HK59989A - Improvements in or relating to nasal pharmaceutical compositions - Google Patents
Improvements in or relating to nasal pharmaceutical compositions Download PDFInfo
- Publication number
- HK59989A HK59989A HK599/89A HK59989A HK59989A HK 59989 A HK59989 A HK 59989A HK 599/89 A HK599/89 A HK 599/89A HK 59989 A HK59989 A HK 59989A HK 59989 A HK59989 A HK 59989A
- Authority
- HK
- Hong Kong
- Prior art keywords
- relating
- pharmaceutical compositions
- nasal administration
- nasal pharmaceutical
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8202781 | 1982-02-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK59989A true HK59989A (en) | 1989-08-04 |
Family
ID=10528017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK599/89A HK59989A (en) | 1982-02-01 | 1989-07-27 | Improvements in or relating to nasal pharmaceutical compositions |
Country Status (27)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0715285D0 (en) * | 2007-08-06 | 2007-09-12 | Britannia Pharmaceuticals Ltd | Improvements in or relating to powdered medicaments for nasal delivery |
| GB0910375D0 (en) * | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
| WO2019136291A1 (en) * | 2018-01-05 | 2019-07-11 | Impel Neuropharma, Inc. | Intranasal delivery of dihydroergotamine by precision olfactory device |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3091569A (en) * | 1960-08-26 | 1963-05-28 | Mead Johnson & Co | Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus |
| GB1202885A (en) * | 1966-12-22 | 1970-08-19 | Sandoz Ltd | Pharmaceutical compositions comprising alkaloids |
| DE2750090A1 (de) * | 1976-11-19 | 1978-06-01 | Sandoz Ag | Neue verabreichungsformen fuer organische verbindungen |
| FR2387035A1 (fr) * | 1977-04-12 | 1978-11-10 | Cassenne Lab Sa | Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux |
| DE2831728C2 (de) * | 1978-07-19 | 1982-12-23 | Krewel-Werke Gmbh, 5208 Eitorf | Arzneimittel zur Behandlung von Kopfschmerzen |
-
1983
- 1983-01-25 FI FI830245A patent/FI81258C/fi not_active IP Right Cessation
- 1983-01-27 FR FR8301228A patent/FR2539994B1/fr not_active Expired
- 1983-01-28 NZ NZ203117A patent/NZ203117A/en unknown
- 1983-01-28 AU AU10850/83A patent/AU565613B2/en not_active Expired
- 1983-01-28 PH PH28445A patent/PH22198A/en unknown
- 1983-01-28 CH CH495/83A patent/CH653555A5/de not_active IP Right Cessation
- 1983-01-28 NL NL8300325A patent/NL192325C/nl not_active IP Right Cessation
- 1983-01-29 DE DE19833302949 patent/DE3302949A1/de active Granted
- 1983-01-31 BE BE1/10708A patent/BE895750A/fr not_active IP Right Cessation
- 1983-01-31 IE IE187/83A patent/IE54532B1/en not_active IP Right Cessation
- 1983-01-31 LU LU84613A patent/LU84613A1/fr unknown
- 1983-01-31 GR GR70362A patent/GR81320B/el unknown
- 1983-01-31 SE SE8300495A patent/SE454402B/sv not_active IP Right Cessation
- 1983-01-31 CA CA000420539A patent/CA1197783A/en not_active Expired
- 1983-01-31 DK DK038183A patent/DK164771C/da not_active IP Right Cessation
- 1983-01-31 PT PT76166A patent/PT76166B/pt unknown
- 1983-01-31 AT AT0030383A patent/AT385656B/de not_active IP Right Cessation
- 1983-01-31 JP JP58015392A patent/JPS58134017A/ja active Granted
- 1983-01-31 HU HU83323A patent/HU191512B/hu unknown
- 1983-02-01 IL IL67822A patent/IL67822A/xx not_active IP Right Cessation
- 1983-02-01 ZA ZA83673A patent/ZA83673B/xx unknown
- 1983-02-01 ES ES519450A patent/ES8502865A1/es not_active Expired
- 1983-02-01 IT IT47646/83A patent/IT1197558B/it active
-
1987
- 1987-12-30 MY MY766/87A patent/MY8700766A/xx unknown
-
1989
- 1989-05-25 SG SG343/89A patent/SG34389G/en unknown
- 1989-06-21 KE KE3888A patent/KE3888A/xx unknown
- 1989-07-27 HK HK599/89A patent/HK59989A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9425160D0 (en) | Medicaments | |
| MY108748A (en) | Medicaments | |
| NZ226557A (en) | Pharmaceutical compositions for the intranasal administration of a biologically active polypeptide in powder form and process for their preparation | |
| CA2195065A1 (en) | Inhalation composition | |
| ZA924164B (en) | Non-chlorofluorocarbon aerosol formulations | |
| HUT47130A (en) | Process for producing 9alpha-hydroxysteroids, as well as 9(11)-dehydro derivatives and pharmaceutical compositions comprising these active ingredients | |
| MY8600471A (en) | Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa and method for administration thereof | |
| HUT49280A (en) | Ointment for the peroral administration of medicine and process for producing the composition | |
| ATE281828T1 (de) | Nikotininhalator | |
| ZA9811796B (en) | New tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them. | |
| EP0165696A3 (en) | Improved transdermal dosage form | |
| BR9712125A (pt) | Formulação farmaucêutica em aerosol, uso de uma mistura, produto farmacêutico, e, processo de administração de budesonida a um paciente | |
| GB8830380D0 (en) | New derivatives of 17beta-oh 19-nor steroids substituted in the 17alpha position,their preparation,their use as medicaments and pharmaceutical compositions | |
| WO1998013024A3 (en) | Hyaluronic drug delivery system | |
| HUT41644A (en) | Process for producing therapeutic preparation suitable for transdermic treating | |
| PT76314B (en) | Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them | |
| EP0335133A3 (en) | Drug delivery using pulmonary surfactant fo facilitate absorption | |
| AU1935788A (en) | A process for producing an administration and/or dosage form for medically active ingredients of drugs | |
| NZ335938A (en) | Prodrug forms and new analogues of camptothecin, their use as medicaments | |
| DE3068803D1 (en) | The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them | |
| NZ334112A (en) | Aerosol formulation comprising 1,1,1,2,3,3,3-heptafluoropropane, mometasone furoate and ethanol | |
| BG107257A (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
| HK59989A (en) | Improvements in or relating to nasal pharmaceutical compositions | |
| PT86436A (en) | Process for preparing pharmaceutical compositions of human calcitonine | |
| CA2078869A1 (en) | Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |